Support 100 years of independent journalism.

  1. Science & Tech
  2. Coronavirus
22 April 2020updated 06 Oct 2020 9:45am

Head of Imperial team developing vaccine says he’s “very confident“ one will be found

By Samuel Horti

The head of the Imperial College London team developing a coronavirus vaccine has said the virus is “not as difficult a target” as other infections and that he’s “very confident” a vaccine will be found.

Professor Robin Shattock told the Today programme that the virus was relatively stable, which means it should be “very easy to lock our sights” on a target.

“I think we are very confident that some vaccines will come through and work. There are so many groups working on different approaches and the virus is not as difficult a target as some of the things we have seen before.

“The main issue is that it doesn’t seem to be changing very much. So it is a target we have in our sights and it is very different from influenza, which changes every year,” he said.

Yesterday, Health Secretary Matt Hancock said a government-backed clinical trial in Oxford would begin testing its vaccine on humans this week.

Sign up for The New Statesman’s newsletters Tick the boxes of the newsletters you would like to receive. Quick and essential guide to domestic and global politics from the New Statesman's politics team. The New Statesman’s global affairs newsletter, every Monday and Friday. The best of the New Statesman, delivered to your inbox every weekday morning. A handy, three-minute glance at the week ahead in companies, markets, regulation and investment, landing in your inbox every Monday morning. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A weekly dig into the New Statesman’s archive of over 100 years of stellar and influential journalism, sent each Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy